Psychosocial predictors of medication adherence among patients with type 2 diabetes

被引:3
|
作者
Moral de la Rubia, Jose [1 ]
Alejandra Cerda, Maria Teresa [2 ]
机构
[1] UANL, Fac Psicol, C Dr Carlos Canseco 110, Monterrey, NL, Mexico
[2] UANL, Serv Med, Monterrey, NL, Mexico
来源
REVISTA IBEROAMERICANA DE PSICOLOGIA Y SALUD | 2015年 / 6卷 / 01期
关键词
Diabetes; Treatment adherence; Social support; Perception of illness; Educational level;
D O I
10.1016/S2171-2069(15)70003-7
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
A study was designed with the aims of estimating the prevalence of patients with medication adherence problems, and studying the association between the number of adhesion problems and socio-demographic variables, clinical variables, illness perception and support social. For this purpose, a probability sample of 289 patients treated in the Diabetes Clinic of the Medical Service of the Autonomous University of Nuevo Leon (UANL), Mexico, was selected. A scale of medication adherence, a questionnaire of illness perception and two social support scales were applied to this clinical sample. The results showed that the prevalence of problems of adherence to treatment was significant. Medication adherence was predicted by greater perceived improvement owing to treatment and by being older. This model had a close fit to the data by the Maximum Likelihood method. It is concluded that the medication that produces improvement perceived by the patient is the most important variable to predictive the medication adhesion. (C) 2014 Sociedad Universitaria de InvestigaciOn en Psicologia y Salud. Published by ELSEVIER ESPANA, S.L.U. This is an open -access article distributed under the terms of the Creative Commons CC BY-NC ND Licence (http: \\creativecommons.org/licenses/by-nc- nd/3.00.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 50 条
  • [1] Predictors of Adherence to Type 2 Diabetes Medication
    Pirdehghan, Azar
    Poortalebi, Nafise
    JOURNAL OF RESEARCH IN HEALTH SCIENCES, 2016, 16 (02) : 72 - 75
  • [2] Holistic psychosocial determinants of adherence to medication in people with type 2 diabetes
    Reach, G.
    Pellan, M.
    Crine, A.
    Touboul, C.
    Ciocca, A.
    Djoudi, Y.
    DIABETES & METABOLISM, 2018, 44 (06) : 500 - 507
  • [3] Psychosocial predictors of medication adherence among persons living with HIV
    Gauchet, Aurelie
    Tarquinio, Cyril
    Fischer, Gustave
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2007, 14 (03) : 141 - 150
  • [4] Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes - A Review
    Swiatoniowska-Lonc, Natalia
    Tanski, Wojciech
    Polanski, Jacek
    Jankowska-Polanska, Beata
    Mazur, Grzegorz
    DIABETES METABOLIC SYNDROME AND OBESITY, 2021, 14 : 2701 - 2715
  • [5] The association between health beliefs and medication adherence among patients with type 2 diabetes
    Alatawi, Yasser M.
    Kavookjian, Jan
    Ekong, Gladys
    Alrayees, Meshari M.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2016, 12 (06): : 914 - 925
  • [6] Measuring Medication Adherence Among Type 2 Diabetes: An Integrative Review
    Conway, Cheryl
    Kelechi, Teresa
    Gregoski, Mathew
    JOURNAL OF NURSING MEASUREMENT, 2020, 28 (01) : 95 - 114
  • [7] Understanding medication adherence among patients of Turkish descent with type 2 diabetes: a qualitative study
    Peeters, Bart
    Van Tongelen, Inge
    Duran, Zehra
    Yuksel, Gulhan
    Mehuys, Els
    Willems, Sara
    Remon, Jean Paul
    Boussery, Koen
    ETHNICITY & HEALTH, 2015, 20 (01) : 87 - 105
  • [8] Medication Adherence and Associated Factors in Patients With Type 2 Diabetes: A Structural Equation Model
    Huang, Jing
    Ding, Shenglan
    Xiong, Shuyuan
    Liu, Zhiping
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [9] A Qualitative Study on the Perception of Medication Adherence by the Social Circles of Patients with Type 2 Diabetes
    Aloudah, Nouf M.
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 973 - 982
  • [10] Medication Adherence Affects Treatment Modifications in Patients With Type 2 Diabetes
    Voorham, Jaco
    Haaijer-Ruskamp, Flora M.
    Wolffenbuttel, Bruce H. R.
    Stolk, Ronald P.
    Denig, Petra
    CLINICAL THERAPEUTICS, 2011, 33 (01) : 121 - 134